These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 32844215)

  • 1. Quality by Design Approach to Develop Stability Indicating Method to Quantify Related Substances and Degradation Products of Sacubitril by High Performance Liquid Chromatography.
    Bommi S; Jayanty S; Tirumalaraju SR; Bandaru S
    J Chromatogr Sci; 2020 Sep; 58(9):844-858. PubMed ID: 32844215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A validated stability-indicating ultra performance liquid chromatography method for the determination of potential process-related impurities in eplerenone.
    Du M; Pan C; Chen J; Song M; Zhu T; Hang T
    J Sep Sci; 2016 Aug; 39(15):2907-18. PubMed ID: 27256957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and validation of a stability-indicating, single HPLC method for sacubitril-valsartan and their stereoisomers and identification of forced degradation products using LC-MS/MS.
    Vijaykumar C; Kumar YR; Aparna P; Rao PSP
    Biomed Chromatogr; 2023 Feb; 37(2):e5550. PubMed ID: 36410774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a validated liquid chromatographic method for quantification of sorafenib tosylate in the presence of stress-induced degradation products and in biological matrix employing analytical quality by design approach.
    Sharma T; Khurana RK; Jain A; Katare OP; Singh B
    Biomed Chromatogr; 2018 May; 32(5):e4169. PubMed ID: 29244215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and validation of a stability indicating assay of doxofylline by RP-HPLC: ESI-MS/MS, ¹H and ¹³C NMR spectroscopic characterization of degradation products and process related impurities.
    Rao RN; Naidu ChG; Prasad KG; Santhakumar B; Saida S
    J Pharm Biomed Anal; 2013 May; 78-79():92-9. PubMed ID: 23466440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stability-indicating reversed-phase-HPLC method development and validation for sacubitril/valsartan complex in the presence of impurities and degradation products: Robustness by quality-by-design approach.
    Subramanian VB; Katari NK; Ponnam V; Konduru N; Dongala T; Marisetti VM; Vyas G
    Biomed Chromatogr; 2022 Jan; 36(1):e5240. PubMed ID: 34486750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and validation of a novel stability-indicating HPLC method for the quantitative determination of eleven related substances in ezetimibe drug substance and drug product.
    Luo Z; Deng Z; Liu Y; Wang G; Yang W; Hou C; Tang M; Yang R; Zhou H
    Talanta; 2015 Jul; 139():67-74. PubMed ID: 25882410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A validated stability-indicating RP-HPLC method for levofloxacin in the presence of degradation products, its process related impurities and identification of oxidative degradant.
    Lalitha Devi M; Chandrasekhar KB
    J Pharm Biomed Anal; 2009 Dec; 50(5):710-7. PubMed ID: 19632800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of an effective novel validated stability-indicating HPLC method for the resolution of brivaracetam stereoisomeric impurities.
    Baksam V; N S; Pocha VR; Chakka VB; Ummadi RR; Kumar P
    Chirality; 2020 Sep; 32(9):1208-1219. PubMed ID: 32656914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. UPLC and LC-MS studies on degradation behavior of irinotecan hydrochloride and development of a validated stability-indicating ultra-performance liquid chromatographic method for determination of irinotecan hydrochloride and its impurities in pharmaceutical dosage forms.
    Kumar N; Sangeetha D; Reddy SP
    J Chromatogr Sci; 2012 Oct; 50(9):810-9. PubMed ID: 22661461
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a new stability indicating method for the simultaneous separation of voriconazole from its impurities along with sodium benzoate used as a preservative in a powder for oral suspension.
    Elleuch A; Louati K; Turki M; Khalfallah K; Safta F
    Ann Pharm Fr; 2019 Sep; 77(5):394-417. PubMed ID: 31257019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stability-indicating LC method for the estimation of bendamustine hydrochloride and its related impurities.
    Kasa S; Raja Sekhar Reddy M; Kadaboina RS; Murki V; Mulukutla VS
    J Chromatogr Sci; 2014 Aug; 52(7):573-83. PubMed ID: 23825351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impurity profiling and a stability-indicating UPLC method development and validation for the estimation of related impurities of halobetasol propionate in halobetasol propionate 0.05% (w/w) cream.
    Prakash L; Malipeddi H; Subbaiah BV; Lakka NS
    J Chromatogr Sci; 2015 Jan; 53(1):112-21. PubMed ID: 24795078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Validated Stability-Indicating Liquid Chromatographic Method for the Determination of Lorcaserin and Related Impurities in DRUG Substance Supported by Quality by Design.
    Wani DV; Mokale SN
    J Chromatogr Sci; 2020 Jul; 58(7):661-671. PubMed ID: 32642780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of Novel RP-HPLC Method for Separation and Estimation of Critical Geometric Isomer and Other Related Impurities of Tafluprost Drug Substance and Identification of Major Degradation Compounds by Using LC-MS.
    Sreenivasulu J; Venkata Ramana P; Sampath Kumar Reddy G; Rakesh M; Nagaraju ChV; Thirumalai Rajan S; Eswaraiah S; Kishore M; Ramakrishna M
    J Chromatogr Sci; 2016 Sep; 54(8):1397-407. PubMed ID: 27226462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stability indicating reverse phase high performance liquid chromatography method for the estimation of capsaicin.
    Shrivastava A; Saxena P
    Pharm Methods; 2011 Apr; 2(2):135-42. PubMed ID: 23781444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A validated specific stability-indicating RP-HPLC assay method for Ambrisentan and its related substances.
    Narayana MB; Chandrasekhar KB; Rao BM
    J Chromatogr Sci; 2014 Sep; 52(8):818-25. PubMed ID: 23926121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Using an innovative Quality-by-Design approach for development of a stability indicating UHPLC method for ebastine in the API and pharmaceutical formulations.
    Schmidt AH; Molnár I
    J Pharm Biomed Anal; 2013 May; 78-79():65-74. PubMed ID: 23454599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stability indicating LC method for rapid determination of related substances of O-desmethyl venlafaxine in active pharmaceutical ingredients and pharmaceutical formulations.
    Rao KV; Reddy KP; Kumar YR
    J Chromatogr Sci; 2014; 52(10):1247-54. PubMed ID: 24474426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantification of halobetasol propionate and its impurities present in topical dosage forms by stability-indicating LC method.
    Nalwade S; Reddy VR; Kulkarni D; Todamal S
    J Chromatogr Sci; 2015 Jan; 53(1):127-34. PubMed ID: 24784115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.